Immune System / Vaccines News From Medical News Today
Latest Immune System / Vaccines News From Medical News Today.
- Last build:
- Language:
- en-us
- Feed URL:
- http://www.medicalnewstoday.com/rss/immune_system.xml
RSS FEED IDEMS: Immune System / Vaccines News From Medical News Today
- Immune Rejection Problems May Be Solved By Embryonic Stem Cells
Tissues derived from embryonic stem (ES) cells could help to pacify the immune system and so prevent recipients from rejecting them, the UK National Stem Cell Network Science Meeting heard.
Mon, 14 Apr 2008 03:00:00 PDT - ECDC Warns Of Upsurge Of Measles In Europe: Unvaccinated People Are At Risk
In 2007, several European countries experienced high numbers of measles cases, notably Switzerland, and to a lesser extent the United Kingdom (UK) and Romania (more than one case per 100,000 population per year). Full data for measles cases in Europe for 2007 can be found on the website of EUVAC.Net, a European Union (EU) -funded Surveillance Community Network for Vaccine Preventable Infectious Diseases [1]. So far in 2008, over 1,300 measles cases have been reported in Europe.
Fri, 11 Apr 2008 05:00:00 PDT - T-Cell Multiplication Unexpectedly Delayed After Infection
In a surprising outcome that overturns the conventional wisdom on the body's immune response to infection, scientists at The Scripps Research Institute have shown that T cells do not begin proliferation until up to three days after infection.Until now, it was generally believed that memory T cells, lymphocytes that recognize pathogens from previous infections, begin cell division at a far earlier point than naïve T cells, fresh cells that respond to new infections.
Fri, 11 Apr 2008 04:00:00 PDT - Radiation Protection Drug Shows Promise In Animal Tests
Scientists in the US have developed a drug that protected laboratory mice and monkeys from radiation damage and may one day be used to protect people from the side effects of radiation used in medical procedures such as cancer treatments, and even the effects of nuclear weapons.
Fri, 11 Apr 2008 03:00:00 PDT - Wellmune WGP Supplementation Research Results Presented At Experimental Biology 2008 Meeting
Wellmune WGP®, a natural immune-enhancing ingredient from Biothera, reduced the incidence of fever and eliminated the need for study subjects to miss work or school due to the cold-like symptoms, researchers reported at the 2008 Experimental Biology annual meeting.Don Cox, Ph.D.
Thu, 10 Apr 2008 03:00:00 PDT - Mumps Resurged In United States
Despite the widespread use of a second dose of mumps vaccine in the US, the largest outbreak for two decades occurred in 2006, prompting calls for a more effective vaccine or changes in policy.Viral disease investigators from the US Centers for Disease Control and Prevention, and other colleagues from various state department health authorities, reported this finding in the April 10th issue of the New England Journal of Medicine.
Thu, 10 Apr 2008 03:00:00 PDT - Blocking The Effect Of Inflammation-Causing Cells Lowered Prostate Cancer Cells Invasion
Recent studies have suggested an association between chronic inflammation and cancers of the prostate, colon, stomach and liver. Now scientists at Northwestern University Feinberg School of Medicine report success in blocking an early step in metastasis of prostate cancer cells by interrupting the communication between the cancer cells and other cells that promote inflammation.Their success suggests new ways to control cancer spread and metastasis.
Thu, 10 Apr 2008 01:00:00 PDT - Solving The Z Ring's Mysteries May Lead To New Antibiotics
A team led by Johns Hopkins researchers has solved important puzzles concerning how certain proteins guide the reproduction of bacteria, discoveries that could lead to a new type of antibiotics.In a recent study published in the journal Current Biology, the scientists reported how a belt-like structure called a Z ring, which pinches a rod-shaped bacterium to produce two offspring, can be disabled by a protein called MinC.
Thu, 10 Apr 2008 01:00:00 PDT - New Wesley Research Institute Study Aims To Halt The Progression Of Multiple Sclerosis
A new research study being conducted at The Wesley Research Institute (WRI) aims to stop the progression of early active stage Multiple Sclerosis (MS) in its tracks.There are currently more than 2.5 million people worldwide with MS, a chronic disease that affects the central nervous system.
Wed, 09 Apr 2008 02:00:00 PDT - Examining The Avian Flu: From Pandemic Planning To Vaccine Development
The journal Respirology has launched a special supplementary issue on the avian influenza. Published by Wiley-Blackwell, the collection of papers present an inclusive insight into the threat of the avian influenza pandemic by addressing a wide range of topics including the basic biology of the virus, updates on laboratory diagnosis and influenza anti-viral, treatment options, and pandemic planning.
Wed, 09 Apr 2008 01:00:00 PDT - Adults Need Protection Against Vaccine Preventable Diseases, Too
Protection against vaccine-preventable diseases is not only recommended for children. Adults, too, need protection.
Wed, 09 Apr 2008 00:00:00 PDT - Letters To Editor Respond To Opinion Piece Addressing AIDS Vaccine Research
The Baltimore Sun on Saturday published two letters to the editor written in response to a March 23 Sun opinion piece by Homayoon Khanlou and Michael Weinstein of the AIDS Healthcare Foundation. Khanlou and Weinstein wrote that the U.S.
Tue, 08 Apr 2008 12:00:00 PDT - Pediatrician Advice Followed By Parents Concerning MMR Vaccinations
News stories about an allegedly harmful link between the mumps, measles and rubella vaccine and the onset of autism had little effect on whether U.S. parents immunized their children, according to a review of immunization records and news stories. Parents' decisions were more likely influenced by recommendations from their child's pediatrician, the researchers said.
Tue, 08 Apr 2008 03:00:00 PDT - Parion Sciences Announces Phase I Clinical Results For Novel Dry Mouth Treatment
Parion Sciences, Inc., a privately-held, development-stage pharmaceutical company dedicated to treating diseases resulting from the failure of the body's mucosal defenses, announced preliminary results from a Phase I clinical safety study of a novel sodium channel blocker, P-552-02, as a topical therapy for dry mouth associated with primary Sjogren's syndrome.
Tue, 08 Apr 2008 00:00:00 PDT - Increased Levels Of Certain Protein Linked To Risk Of Coronary Heart Disease
An article published in the open-access journal PLoS Medicinefindsthat there is a link between coronary heart disease and levels ofinterleukin-6 (IL-6), a protein triggered by inflammation thatattracts immune system cells to an injury site. John Danesh(University of Cambridge) and colleagues also suggest that new drugsdesigned to fight vascular disease may target the IL-6 protein.
Tue, 08 Apr 2008 00:00:00 PDT
